Filtros de búsqueda

Lista de obras de

A Cancer and Leukemia Group B multi-center study of DA-EPOCH-rituximab in untreated diffuse large B-cell lymphoma with analysis of outcome by molecular subtype.

artículo científico publicado en 2011

A Probabilistic Classification Tool for Genetic Subtypes of Diffuse Large B Cell Lymphoma with Therapeutic Implications

scientific article published on 01 April 2020

A multiprotein supercomplex controlling oncogenic signalling in lymphoma

artículo científico publicado en 2018

A new prognostic score for AIDS-related lymphomas in the rituximab-era

artículo científico publicado en 2014

A novel role for IL-22R1 as a driver of inflammation

artículo científico publicado en 2010

A pilot study of CTLA-4 blockade after cancer vaccine failure in patients with advanced malignancy

article

A pilot study of the value of 18F-fluoro-deoxy-thymidine PET/CT in predicting viable lymphoma in residual 18F-FDG avid masses after completion of therapy

artículo científico publicado en 2014

A prospective study of mediastinal gray-zone lymphoma

artículo científico publicado en 2014

ABVD plus rituximab ABVD alone for advanced stage, high-risk classical Hodgkin lymphoma: a randomized phase 2 study

artículo científico publicado en 2018

ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes.

artículo científico publicado en 2014

Acquired immunodeficiency syndrome-related malignancies in the era of highly active antiretroviral therapy

artículo científico publicado en 2006

Activation of CD44, a receptor for extracellular matrix components, protects chronic lymphocytic leukemia cells from spontaneous and drug induced apoptosis through MCL-1

artículo científico publicado en 2011

Aggressive natural killer cell leukemia/lymphoma: case report, use of telesynergy and review of the literature

artículo científico publicado en 2004

Albumin enhanced morphometric image analysis in CLL.

artículo científico publicado en 2004

Alternating MOPP and ABVD chemotherapy plus mantle-field radiation therapy in patients with massive mediastinal Hodgkin's disease ⬇️

artículo científico publicado el 1 de noviembre de 1997

Angioimmunoblastic T cell lymphoma: pathobiological insights and clinical implications

artículo científico publicado en 2007

Angioimmunoblastic T-cell lymphoma: immune modulation as a therapeutic strategy

scientific article published on 01 March 2007

Appropriate management of molecular subtypes of diffuse large B-cell lymphoma

artículo científico

Association of lymphomatoid granulomatosis with Epstein-Barr viral infection of B lymphocytes and response to interferon-alpha 2b

artículo científico publicado en 1996

Autoreactive, cytotoxic T lymphocytes specific for peptides derived from normal B-cell differentiation antigens in healthy individuals and patients with B-cell malignancies

artículo científico publicado en 2004

B-cell lymphoma in a patient with complete interferon gamma receptor 1 deficiency

artículo científico publicado en 2013

B-cell recovery following rituximab-based therapy is associated with perturbations in stromal derived factor-1 and granulocyte homeostasis

artículo científico publicado en 2005

BCL-6 and rituximab in diffuse large B-cell lymphoma: where are we?

scientific article published on 01 January 2007

Baseline mutational patterns and sustained MRD negativity in patients with high-risk smoldering myeloma

article

Bcl-2 level as a biomarker for 13q14 deletion in CLL.

artículo científico publicado en 2013

Bendamustine and rituximab in relapsed and refractory hairy cell leukemia

artículo científico publicado en 2013

Beyond RCHOP: A Blueprint for Diffuse Large B Cell Lymphoma Research

artículo científico publicado en 2016

Biology and management of rare primary extranodal T-cell lymphomas.

scientific article published on January 2010

Bortezomib resistance in mantle cell lymphoma is associated with plasmacytic differentiation

artículo científico publicado en 2010

Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics

artículo científico publicado en 2012

CNS involvement in primary mediastinal large B-cell lymphoma

artículo científico publicado en 1999

Cardiac involvement with lymphoma: a review of the literature

artículo científico publicado en 2008

Central nervous system involvement in AIDS-related lymphomas

artículo científico publicado en 2016

Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States

artículo científico publicado en 2011

Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma

artículo científico publicado en 2010

Circulating Tumor DNA Measurements As Early Outcome Predictors in Diffuse Large B-Cell Lymphoma

artículo científico publicado en 2018

Circulating serum free light chains as predictive markers of AIDS-related lymphoma

artículo científico publicado en 2010

Circulating tumour DNA and CT monitoring in patients with untreated diffuse large B-cell lymphoma: a correlative biomarker study

artículo científico publicado en 2015

Cladribine with immediate rituximab for the treatment of patients with variant hairy cell leukemia

artículo científico publicado en 2013

Clinical Reversal of Multidrug Resistance

artículo científico publicado en 1996

Clinical reversal of multidrug resistance

artículo científico publicado en 1996

Coexisting and clonally identical classic hodgkin lymphoma and nodular lymphocyte predominant hodgkin lymphoma.

artículo científico publicado en 2011

Combination chemotherapy followed by an immunotoxin (anti-B4-blocked ricin) in patients with indolent lymphoma: results of a phase II study

artículo científico publicado en 2000

Combined normal donor and CLL: Single tube ZAP-70 analysis

artículo científico publicado en 2011

Complete Remissions of Adult T-cell Leukemia with Anti-CD25 Recombinant Immunotoxin LMB-2 and Chemotherapy to Block Immunogenicity

artículo científico publicado en 2015

Construction and preclinical evaluation of an anti-CD19 chimeric antigen receptor

artículo científico publicado en 2009

Controlled trial of dexverapamil, a modulator of multidrug resistance, in lymphomas refractory to EPOCH chemotherapy ⬇️

artículo científico publicado el 1 de agosto de 1995

Cracking the diverse biologic code of diffuse large B-cell lymphoma

scientific article published on 21 January 2015

Cutaneous lymphomatoid granulomatosis: correlation of clinical and biologic features

scientific article published on 01 September 2001

Cyclin D1-negative mantle cell lymphoma: a clinicopathologic study based on gene expression profiling

artículo científico publicado en 2005

DOCK 8 Deficiency, EBV+ Lymphomatoid Granulomatosis, and Intrafamilial Variation in Presentation.

artículo científico publicado en 2017

Decitabine in older adults with acute myeloid leukemia: why was the dream broken?

artículo científico publicado en 2013

Decoding the DNA Methylome of Mantle Cell Lymphoma in the Light of the Entire B Cell Lineage.

artículo científico publicado en 2016

Decreased mitochondrial apoptotic priming underlies stroma-mediated treatment resistance in chronic lymphocytic leukemia

artículo científico publicado en 2012

Detection and outcome of occult leptomeningeal disease in diffuse large B-cell lymphoma and Burkitt lymphoma.

artículo científico publicado en 2014

Detection of malignant hematopoietic cells in cerebral spinal fluid previously diagnosed as atypical or suspicious

scientific article published on 01 June 2006

Development of Hepatic Steatosis After Chemotherapy for Non-Hodgkin Lymphoma

artículo científico publicado en 2018

Diagnostic tools for neoplastic meningitis: detecting disease, identifying patient risk, and determining benefit of treatment

artículo científico publicado en 2009

Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphoma

artículo científico publicado en 2009

Differential role of BCL2 in molecular subtypes of diffuse large B-cell lymphoma

artículo científico publicado en 2011

Diffuse large B cell lymphoma: molecular targeted therapy

artículo científico publicado en 2012

Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction

artículo científico publicado en 2005

Diffuse large B-cell lymphoma-treatment approaches in the molecular era.

artículo científico publicado en 2013

Dose-Adjusted EPOCH-R Compared With R-CHOP as Frontline Therapy for Diffuse Large B-Cell Lymphoma: Clinical Outcomes of the Phase III Intergroup Trial Alliance/CALGB 50303

artículo científico publicado en 2019

Dose-adjusted EPOCH chemotherapy for untreated large B-cell lymphomas: a pharmacodynamic approach with high efficacy

artículo científico publicado en 2002

Dose-adjusted EPOCH-R (etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab) in untreated aggressive diffuse large B-cell lymphoma with MYC rearrangement: a prospective, multicentre, single-arm phase 2 study

artículo científico publicado en 2018

Dose-adjusted EPOCH-R therapy in MYC-rearranged diffuse large B-cell lymphoma: not yet the standard of care - Authors' reply

scientific article published on 01 March 2019

Dose-adjusted EPOCH-rituximab combined with fludarabine provides an effective bridge to reduced-intensity allogeneic hematopoietic stem-cell transplantation in patients with lymphoid malignancies

artículo científico publicado en 2012

Dose-adjusted EPOCH-rituximab therapy in primary mediastinal B-cell lymphoma

artículo científico publicado en 2013

Drug resistance in adult lymphomas

artículo científico publicado en 1994

Drug resistance in diffuse large B-cell lymphoma

artículo científico publicado en 2006

Dynamic Risk Profiling Using Serial Tumor Biomarkers for Personalized Outcome Prediction

scientific article published on 04 July 2019

Dynamic monitoring of circulating tumor DNA in non-Hodgkin lymphoma.

artículo científico publicado en 2016

EBV-associated lymphomas in adults

artículo científico publicado en 2012

EPOCH chemotherapy: toxicity and efficacy in relapsed and refractory non-Hodgkin's lymphoma ⬇️

artículo científico publicado el 1 de agosto de 1993

Efficacy of reduced-intensity allogeneic stem cell transplantation in chemotherapy-refractory non-hodgkin lymphoma

artículo científico publicado en 2005

Egress of CD19(+)CD5(+) cells into peripheral blood following treatment with the Bruton tyrosine kinase inhibitor ibrutinib in mantle cell lymphoma patients

artículo científico publicado en 2013

Elevated interleukin-10: a new cause of dyslipidemia leading to severe HDL deficiency

artículo científico publicado en 2014

Elevated serum-soluble interleukin-2 receptor levels in patients with anaplastic large cell lymphoma

artículo científico publicado en 2004

Emerging therapeutic paradigms to target the dysregulated Janus kinase/signal transducer and activator of transcription pathway in hematological malignancies

artículo científico publicado en 2014

End-of-treatment and serial PET imaging has prognostic value and clinical utility in primary mediastinal B-cell lymphoma following dose-adjusted EPOCH-R - Response to Adams et al

scientific article published on 01 August 2018

End-of-treatment and serial PET imaging in primary mediastinal B-cell lymphoma following dose-adjusted EPOCH-R: a paradigm shift in clinical decision making

scientific article published on 10 May 2018

Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19 ⬇️

artículo científico publicado el 28 de julio de 2010

Establishment of early donor engraftment after reduced-intensity allogeneic hematopoietic stem cell transplantation to potentiate the graft-versus-lymphoma effect against refractory lymphomas

artículo científico publicado en 2003

Expanding the Precision Medicine Toolkit With Circulating Tumor DNA

scientific article published on 01 September 2020

Expression of the multidrug resistance-associated protein gene in refractory lymphoma: quantitation by a validated polymerase chain reaction assay

artículo científico publicado en 1997

Extraoular muscle palsies in subcutaneous panniculitis-like T-cell lymphoma

artículo científico publicado en 2003

FDG-PET lymphoma demonstration project invitational workshop

scientific article published on 01 March 2007

Female fertility following dose-adjusted EPOCH-R chemotherapy in primary mediastinal B-cell lymphomas

artículo científico publicado en 2016

Flow cytometric immunophenotypic profiles of mature gamma delta T-cell malignancies involving peripheral blood and bone marrow

artículo científico publicado en 2005

Flow cytometric immunophenotyping of cerebrospinal fluid

artículo científico publicado en 2008

Fludarabine treatment of patients with chronic lymphocytic leukemia induces a p53-dependent gene expression response

artículo científico publicado en 2004

Fluorodeoxyglucose positron emission tomography (FDG-PET) for monitoring lymphadenopathy in the autoimmune lymphoproliferative syndrome (ALPS).

artículo científico publicado en 2006

Fluorodeoxyglucose positron emission tomography in the presence of cardiac metastases

artículo científico publicado en 2003

Focus on lymphomas

artículo científico publicado en 2002

Gene Expression Profiling of Mediastinal Gray Zone Lymphoma and Its Relationship to Primary Mediastinal B-cell Lymphoma and Classical Hodgkin Lymphoma

scientific article published on 30 March 2020

Genetic polymorphism in MDR-1: a tool for examining allelic expression in normal cells, unselected and drug-selected cell lines, and human tumors.

artículo científico publicado en 1998

Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma.

artículo científico publicado en 2018

Genetics of Diffuse Large B-Cell Lymphoma

article

Genome-wide discovery of somatic coding and noncoding mutations in pediatric endemic and sporadic Burkitt lymphoma

artículo científico publicado en 2019

Genomewide DNA methylation analysis reveals novel targets for drug development in mantle cell lymphoma.

artículo científico publicado en 2010

Good outcome of AIDS-related Burkitt lymphoma (BL) and diffuse large B-cell lymphoma (DLBCL) with abbreviated cycles of EPOCH-rituximab

artículo científico publicado en 2009

Gray zone lymphoma: better treated like hodgkin lymphoma or mediastinal large B-cell lymphoma?

artículo científico

Gray zone lymphoma: chromosomal aberrations with immunophenotypic and clinical correlations.

artículo científico publicado en 2011

Harnessing Noxa demethylation to overcome Bortezomib resistance in mantle cell lymphoma

artículo científico publicado en 2015

High incidence of occult leptomeningeal disease detected by flow cytometry in newly diagnosed aggressive B-cell lymphomas at risk for central nervous system involvement: the role of flow cytometry versus cytology

artículo científico publicado en 2004

High-dose continuous infusion beta-lactam antibiotics for the treatment of resistant Pseudomonas aeruginosa infections in immunocompromised patients

artículo científico publicado en 2010

Highly effective treatment of acquired immunodeficiency syndrome-related lymphoma with dose-adjusted EPOCH: impact of antiretroviral therapy suspension and tumor biology

artículo científico publicado en 2003

Hybrid dosing of the cyclin-dependent kinase (CDK) inhibitor flavopiridol in relapsed/refractory mantle cell lymphoma and diffuse large B-cell lymphoma

scientific article published on 17 June 2019

Immunophenotypic features distinguishing familial chronic lymphocytic leukemia from sporadic chronic lymphocytic leukemia

artículo científico

Implications of the shifting pathobiology of AIDS-related lymphoma

artículo científico publicado en 2013

Improved ZAP-70 assay using two clones, multiple methods of analysis and clinical correlation

artículo científico publicado en 2011

Improved classification of leukemic B-cell lymphoproliferative disorders using a transcriptional and genetic classifier.

artículo científico publicado en 2017

Improved survival in chronic lymphocytic leukemia in the past decade: a population-based study including 11,179 patients diagnosed between 1973-2003 in Sweden

scientific article published on September 2009

Infection of mesothelial cells with human herpes virus 8 in human immunodeficiency virus-infected patients with Kaposi's sarcoma, Castleman's disease, and recurrent pleural effusions

artículo científico publicado en 2003

Inhibition of B Cell Receptor Signaling by Ibrutinib in Primary CNS Lymphoma

artículo científico publicado en 2017

Inhibition of Bruton tyrosine kinase in patients with severe COVID-19

artículo científico publicado en 2020

Inhibitor of histone deacetylation, depsipeptide (FR901228), in the treatment of peripheral and cutaneous T-cell lymphoma: a case report

artículo científico publicado en 2001

International Central Nervous System and Ocular Lymphoma Workshop: recommendations for the future

artículo científico publicado en 2006

International consensus recommendations on the flow cytometric immunophenotypic analysis of hematolymphoid neoplasia

scientific article published on 01 January 2007

Landscape of somatic mutations and clonal evolution in mantle cell lymphoma.

artículo científico publicado en 2013

Lenalidomide-induced upregulation of CD80 on tumor cells correlates with T-cell activation, the rapid onset of a cytokine release syndrome and leukemic cell clearance in chronic lymphocytic leukemia

scientific article published on September 2009

Liquid biopsy in non-Hodgkin's lymphoma

artículo científico publicado en 2019

Low-intensity therapy in adults with Burkitt's lymphoma.

artículo científico publicado en 2013

Lymphomatoid granulomatosis

artículo científico publicado en 2012

Lymphomatoid granulomatosis and other Epstein-Barr virus associated lymphoproliferative processes

artículo científico publicado en 2012

Lymphomatoid granulomatosis with involvement of the hard palate: a case report

artículo científico publicado en 2008

Lymphomatoid granulomatosis--a single institute experience: pathologic findings and clinical correlations

artículo científico publicado en 2015

Lymphomatoid granulomatosis: abnormalities of the brain at MR imaging

artículo científico publicado en 2005

Lymphomatoid granulomatosis: pathogenesis, pathology and clinical implications

artículo científico publicado en 1997

MYC gene rearrangement in diffuse large B-cell lymphoma does not confer a worse prognosis following dose-adjusted EPOCH-R.

artículo científico publicado en 2017

Magnesium Restores Activity to Peripheral Blood Cells in a Patient With Functionally Impaired Interleukin-2-Inducible T Cell Kinase

artículo científico publicado en 2019

Management of heavy chain diseases: the challenges of biologic heterogeneity

Mantle cell lymphoma: report of the 2009 Mantle Cell Lymphoma Consortium Workshop

artículo científico publicado en 2010

Mantle cell lymphoma: report of the 2010 Mantle Cell Lymphoma Consortium Workshop

artículo científico publicado en 2010

Methodological comparison of two anti-ZAP-70 antibodies

artículo científico publicado en 2011

Methylation profiling of mediastinal gray zone lymphoma reveals a distinctive signature with elements shared by classical Hodgkin's lymphoma and primary mediastinal large B-cell lymphoma

artículo científico publicado en 2011

Minimal residual hairy cell leukemia eradication with moxetumomab pasudotox: phase I results and long-term follow-up.

artículo científico publicado en 2018

Modulation of clinical drug resistance in a B cell lymphoma patient by the protein kinase inhibitor 7-hydroxystaurosporine: presentation of a novel therapeutic paradigm.

artículo científico publicado en 2000

Modulation of multidrug resistance by dexverapamil in EPOCH-refractory lymphomas.

artículo científico publicado en 1995

Molecular Classification and Treatment of Diffuse Large B-Cell Lymphoma and Primary Mediastinal B-Cell Lymphoma

artículo científico publicado en 2020

Molecular diagnosis of Burkitt's lymphoma

artículo científico publicado en 2006

Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma

artículo científico publicado en 2003

Molecular subsets of mantle cell lymphoma defined by the IGHV mutational status and SOX11 expression have distinct biologic and clinical features

artículo científico publicado en 2012

Monitoring clinical outcomes in aggressive B-cell lymphoma: From imaging studies to circulating tumor DNA

scientific article published on 03 July 2018

Moving beyond rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone for diffuse large B-cell lymphoma

artículo científico

Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia

scholarly article by Robert J Kreitman et al published August 2018 in Leukemia

Multicenter Study of Risk-Adapted Therapy With Dose-Adjusted EPOCH-R in Adults With Untreated Burkitt Lymphoma

artículo científico publicado en 2020

Mycosis fungoides and Sézary syndrome

artículo científico publicado en 2008

NK-cell enteropathy: a benign NK-cell lymphoproliferative disease mimicking intestinal lymphoma: clinicopathologic features and follow-up in a unique case series

artículo científico publicado en 2010

Navitoclax, a targeted high-affinity inhibitor of BCL-2, in lymphoid malignancies: a phase 1 dose-escalation study of safety, pharmacokinetics, pharmacodynamics, and antitumour activity ⬇️

artículo científico publicado el 18 de noviembre de 2010

Neutropenia associated with rituximab therapy

artículo científico publicado el 1 de enero de 2011

New Strategies in Peripheral T-Cell Lymphoma: Understanding Tumor Biology and Developing Novel Therapies ⬇️

artículo científico publicado el 1 de diciembre de 2010

Nodal and extranodal plasmacytomas expressing immunoglobulin a: an indolent lymphoproliferative disorder with a low risk of clinical progression

artículo científico publicado en 2010

Nodal involvement by cutaneous CD30-positive T-cell lymphoma mimicking classical Hodgkin lymphoma.

artículo científico publicado en 2012

Non-Hodgkin's lymphoma in Job's syndrome: a case report and literature review

artículo científico publicado en 2004

Novel CD19 expression in a peripheral T cell lymphoma: A flow cytometry case report with morphologic correlation

artículo científico publicado en 2009

Novel agents for B-cell non-Hodgkin lymphoma: science and the promise

artículo científico publicado en 2010

Novel disease targets and management approaches for diffuse large B-cell lymphoma

artículo científico publicado en 2010

Oropharyngeal shedding of Epstein-Barr virus in the absence of circulating B cells

artículo científico publicado en 2008

PD-1 Blockade in Mediastinal Gray-Zone Lymphoma.

artículo científico publicado en 2017

Paclitaxel in doxorubicin-refractory or mitoxantrone-refractory breast cancer: a phase I/II trial of 96-hour infusion.

artículo científico publicado en 1994

Pathobiology and Treatment of Lymphomatoid Granulomatosis; A Rare EBV-Driven Disorder

scientific article published on 27 February 2020

Pathogenic B-cell receptor signaling in lymphoid malignancies: New insights to improve treatment

artículo científico publicado en 2019

Pathogenic role of B-cell receptor signaling and canonical NF-κB activation in mantle cell lymphoma

artículo científico publicado en 2016

Persistent non-neoplastic gammadelta-T cells in cerebrospinal fluid of a patient with hepatosplenic (gammadelta) T cell lymphoma: a case report with 6 years of flow cytometry follow-up.

artículo científico publicado en 2009

Phase 1/2 study of alemtuzumab with dose-adjusted EPOCH in untreated aggressive T and NK cell lymphomas

scientific article published on 10 January 2019

Phase I and pharmacokinetic study of the multidrug resistance modulator dexverapamil with EPOCH chemotherapy ⬇️

artículo científico publicado el 1 de agosto de 1995

Phase I dose escalation study of the anti-CD2 monoclonal antibody, siplizumab, with DA-EPOCH-R in aggressive peripheral T-cell lymphomas.

artículo científico publicado en 2017

Phase I trial of 7-hydroxystaurosporine and fludararbine phosphate: in vivo evidence of 7-hydroxystaurosporine induced apoptosis in chronic lymphocytic leukemia.

artículo científico publicado en 2011

Phase I trial of anti-CD22 recombinant immunotoxin moxetumomab pasudotox (CAT-8015 or HA22) in patients with hairy cell leukemia

artículo científico publicado en 2012

Phase I trial of recombinant immunotoxin RFB4(dsFv)-PE38 (BL22) in patients with B-cell malignancies

artículo científico publicado en 2005

Phase I trial of recombinant immunotoxin anti-Tac(Fv)-PE38 (LMB-2) in patients with hematologic malignancies

artículo científico publicado en 2000

Phase II and dose-escalation with or without granulocyte colony-stimulating factor study of 9-aminocamptothecin in relapsed and refractory lymphomas

artículo científico publicado en 1998

Phase II study of dose-adjusted EPOCH and rituximab in untreated diffuse large B-cell lymphoma with analysis of germinal center and post-germinal center biomarkers

artículo científico publicado en 2008

Phase II study of paclitaxel in relapsed non-Hodgkin's lymphomas

scientific article published on 01 February 1995

Phase II trial of dose-adjusted EPOCH in untreated systemic anaplastic large cell lymphoma

artículo científico publicado en 2015

Phase II trial of recombinant immunotoxin RFB4(dsFv)-PE38 (BL22) in patients with hairy cell leukemia

artículo científico publicado en 2009

Point mutations and genomic deletions in CCND1 create stable truncated cyclin D1 mRNAs that are associated with increased proliferation rate and shorter survival

artículo científico publicado en 2007

Precision treatment of distinct molecular subtypes of diffuse large B-cell lymphoma: ascribing treatment based on the molecular phenotype

scientific article published on 01 October 2014

Prediction of Survival in Follicular Lymphoma Based on Molecular Features of Tumor-Infiltrating Immune Cells

article

Primary intraocular lymphoma: current and future perspectives

artículo científico publicado en 2006

Primary mediastinal B-cell lymphoma and mediastinal gray zone lymphoma: do they require a unique therapeutic approach?

artículo científico publicado en 2014

Primary mediastinal large B-cell lymphoma, classic Hodgkin lymphoma presenting in the mediastinum, and mediastinal gray zone lymphoma: what is the oncologist to do?

artículo científico publicado en 2011

Prognostic Value of Interim FDG-PET in Diffuse Large Cell Lymphoma: Results from the CALGB 50303 Clinical Trial

scientific article published on 13 March 2020

Progress in Chronic Lymphocytic Leukemia with Targeted Therapy.

artículo científico publicado en 2016

Prolonged half-life of voriconazole in a CYP2C19 homozygous poor metabolizer receiving vincristine chemotherapy: avoiding a serious adverse drug interaction

artículo científico publicado en 2011

Radiofrequency ablation of lymphoma

artículo científico publicado en 2005

Randomized Phase II Study of First-Line Cladribine With Concurrent or Delayed Rituximab in Patients With Hairy Cell Leukemia

scientific article published on 28 February 2020

Randomized Phase III Trial of Ibrutinib and Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Non-Germinal Center B-Cell Diffuse Large B-Cell Lymphoma.

artículo científico publicado en 2019

Rapid clearance of rituximab may contribute to the continued high incidence of autoimmune hematologic complications of chemoimmunotherapy for chronic lymphocytic leukemia

artículo científico publicado en 2013

Re: Rituximab maintenance for the treatment of patients with follicular lymphoma: systematic review and meta-analysis of randomized trials

artículo científico publicado en 2009

Recombinant immunotoxins and other therapies for relapsed/refractory hairy cell leukemia

artículo científico publicado en 2011

Recombinant immunotoxins for treating cancer

artículo científico publicado en 2004

Reevaluating the accelerated approval process for oncology drugs

artículo científico publicado en 2013

Refining the treatment of follicular lymphoma

artículo científico publicado en 2008

Relationship of p53, bcl-2, and tumor proliferation to clinical drug resistance in non-Hodgkin's lymphomas

artículo científico publicado en 1997

Reply to J. Wang et al

scientific article published on 12 February 2019

Reply to M. Hertzberg et al

scientific article published on 15 September 2020

Reply to M. Skelin et al

artículo científico publicado en 2019

Reply to T.M. Weis et al

artículo científico publicado en 2019

Reversal of Multidrug Resistance

artículo científico publicado en 1994

Reversal of multidrug resistance.

artículo científico publicado en 1994

Rituximab treatment of refractory fludarabine-associated immune thrombocytopenia in chronic lymphocytic leukemia.

artículo científico publicado en 2002

Rituximab-associated neutropenia

artículo científico publicado en 2010

Role of a doxorubicin-containing regimen in relapsed and resistant lymphomas: an 8-year follow-up study of EPOCH.

artículo científico publicado en 2000

Role of molecular subtype in predicting outcome of AIDS-related diffuse large B-cell lymphoma

artículo científico publicado en 2010

Role of the tumor microenvironment in mature B-cell lymphoid malignancies

artículo científico publicado en 2016

Safety and efficacy of navitoclax, a BCL-2 and BCL-XL inhibitor, in patients with relapsed or refractory lymphoid malignancies: results from a phase 2a study

artículo científico publicado en 2020

Stromal gene signatures in large-B-cell lymphomas

artículo científico publicado en 2008

Structural profiles of TP53 gene mutations predict clinical outcome in diffuse large B-cell lymphoma: an international collaborative study.

artículo científico publicado en 2008

T-cell lymphoma

artículo científico publicado en 2013

Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma.

artículo científico publicado en 2015

Targeting CD52 as a novel therapeutic strategy in angioimmunoblastic T-cell lymphoma ⬇️

artículo científico publicado el 1 de septiembre de 2010

Targeting HLA-DR.

artículo científico publicado en 2009

Targeting malignant B cells with an immunotoxin against ROR1

artículo científico publicado en 2012

The BCL-2 biomarker in the era of molecular diagnosis of diffuse large B-cell lymphoma

artículo científico publicado en 2007

The case for rituximab in AIDS-related lymphoma

artículo científico publicado en 2006

The development of liquid biopsy for research and clinical practice in lymphomas: Report of the 15-ICML workshop on ctDNA

artículo científico publicado en 2019

The effects of cardiovascular disease on the clinical outcome of elderly patients with diffuse large B-cell lymphoma.

artículo científico publicado en 2014

The landscape of new drugs in lymphoma

artículo científico publicado en 2016

The lymph node microenvironment promotes B-cell receptor signaling, NF-κB activation, and tumor proliferation in chronic lymphocytic leukemia ⬇️

artículo científico publicado el 12 de octubre de 2010

The pharmacokinetics of rituximab following an intravitreal injection

artículo científico publicado en 2005

The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma

article

The role of MDR-1 in refractory lymphoma

artículo científico publicado en 1997

The role of Mig, the monokine induced by interferon-gamma, and IP-10, the interferon-gamma-inducible protein-10, in tissue necrosis and vascular damage associated with Epstein-Barr virus-positive lymphoproliferative disease ⬇️

artículo científico publicado el 15 de noviembre de 1997

The role of rituximab and chemotherapy in aggressive B-cell lymphoma: a preliminary report of dose-adjusted EPOCH-R.

artículo científico publicado en 2002

The role of tumor histogenesis, FDG-PET, and short-course EPOCH with dose-dense rituximab (SC-EPOCH-RR) in HIV-associated diffuse large B-cell lymphoma

artículo científico publicado en 2010

The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma

artículo científico publicado en 2002

The value of positron emission tomography in prognosis and response assessment in non-Hodgkin lymphoma

artículo científico publicado en 2010

Therapy in primary mediastinal B-cell lymphoma

artículo científico publicado en 2013

Transfusion medicine illustrated. Hemophagocytosis and coagulopathy associated with cutaneous gamma-delta T-cell lymphoma

artículo científico publicado en 2004

Treatment factors affecting outcomes in HIV-associated non-Hodgkin lymphomas: a pooled analysis of 1546 patients.

artículo científico publicado en 2013

Treatment strategies for aggressive lymphomas: what works?

artículo científico publicado en 2013

Treatment-induced oxidative stress and cellular antioxidant capacity determine response to bortezomib in mantle cell lymphoma

artículo científico publicado en 2011

Unique cell surface expression of receptor tyrosine kinase ROR1 in human B-cell chronic lymphocytic leukemia.

artículo científico publicado en 2008

Update on Burkitt Lymphoma

artículo científico publicado en 2016

Update on the Pathogenesis, Diagnosis, and Therapy of AIDS-related Lymphoma

scientific article published on 01 April 2003

Using biologic predictive factors to direct therapy of diffuse large B-cell lymphoma

artículo científico publicado en 2013

Utilization of polymerase chain reaction on archival cytologic material: a comparison with fresh material with special emphasis on cerebrospinal fluids

artículo científico publicado en 2004

Vaccine-induced tumor-specific immunity despite severe B-cell depletion in mantle cell lymphoma.

artículo científico publicado en 2005

Variable CD52 expression in mature T cell and NK cell malignancies: implications for alemtuzumab therapy

artículo científico publicado en 2009

Viral, immunologic, and clinical features of primary effusion lymphoma

artículo científico publicado en 2019

What is the standard of care for primary mediastinal b-cell lymphoma; R-CHOP or DA-EPOCH-R?

artículo científico publicado en 2018

ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile

scientific article published on 20 February 2003

microRNA expression profiles identify subtypes of mantle cell lymphoma with different clinicobiological characteristics

artículo científico publicado en 2013

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda